Skip to navigation  |   Skip to content Gray Theme Black Theme
minus Reset plus
Screen Reader
Drugs Control Department
About Us
Forms and Fees
Manufacturing Units
Sales Licences
Procedures For Obtaining Licences
Procedure for Obtaining Approval as RMI
Approved Testing Laboratories
Blood Bank
Public Notice
Not of Standard Quality Sample
Citizen Charter
RTI Act 2005
Office Order
Drugs Control Circular
Banned Drugs
Centralized Circular
Centralized Order
Centralized Important Schemes
Whats New
Gazette Notification
Drugs Control Gazette Notifications
Recognised Medical Institutions (RMI) in Delhi
Dos n Dont for the Consumers
Tender And Fifth Delhi Finance Commission
Contact Us
What's New

Gazette Notification GSR 724(E) dated 07-11-2013 Ketamine Hydrocloride

Tender Notice for Disposal of Staff Vehicle No. DL 1CF 3312 dated 29-05-2015


Gazette Extraordinary Notification for 'Oseltamivir Phosphate' and 'Zanamivir' G. S. R. 677(E)

Notification for Schedule H & H1 under Drugs & Cosmetics (Fourth Amendment) Rules, 2013 August 30.08.2013 GSR 588 (E)

Gazette Notification 18 June 2013-GSR 378E Analgin.pdf

Gazette Notification 18 June 2013-FLUPENTHIXOL-malitrecin

Gazette Notification - Pioglitazone 18-6-13

  • GSR 332(E) dated: 23-05-2013

  • Inspection Book on Form-35 is now available at the Reception Counter of Our Department.12-09-2012

  • The list of drugs which do not require supervision of a Registered Pharmacist for sale/distribution under licence(s) on Form 20-A and 21-A has been revised.
       Certain drugs which have become obsolete or are no more available in the market have been deleted while some of the important drugs which are considered to be more useful viz. Zinc sulphate tablets/syrup have been included.  For details contact the duty officer.


  • The Ministry of Health & Family Welfare, Govt. of India has banned the manufacture, sales and distribution of Gatifloxacin & Tegaserod and their formulations vide notification no. G.S.R. 218(E) dated 16.03.2011.


The text of the notification published on 31.03.2011 by Ministry in newspaper is given hereunder:-




(Department of Health & Family Welfare)


New Delhi, the 16th March, 2011


G.S.R. 218(E).-Whereas the Central Government is satisfied that use of the following  drugs is likely to involve certain risks to human beings and whereas safer alternatives to the said drugs are available;


And whereas the Central Government is satisfied that it is necessary and expedient to prohibit the manufacture, sale and distribution of the said drugs in public interest;


Now, therefore, in exercise of the powers conferred by Section 26A of the Drugs and Cosmetics Act, 1940 (23 of 1940), the Central Government hereby prohibits the manufacture, sale and distribution of the following drugs with immediate effect, namely  :-


(i)                 Gatifloxacin formulation for systemic use in human by any route including oral and injectable; and

(ii)               Tegaserod and its formulations for human use.





  • Drugs Control Department Government of NCT of Delhi enforces the different provisions of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and the rules framed   the under. The preamble of the said Act reads as under:

An Act to control the advertisement of drugs in certain cases, to prohibit the advertisement for certain purposes of remedies alleged to possess magic qualities and provide for matters connected therewith”.

Drugs Control Department during the period August 2010 to December 2010 has filed six cases before the competent court in Delhi against persons/publishers who had taken part in the publication of different advertisements which had contravened the provisions of the Drugs & Magic Remedies (Objectionable Advertisements) Act, 1954.

Any person who comes across any advertisement(s) which in his/her opinion is false/misreading with respect to any drug can approach any of the following officers either personally or on phone during normal working hours:-

S No.



Phone No.


A.K. Nasa

Asst. Drugs Controller



M.Asad Ansari

Drugs Inspector(Head quarter)



Suitable action in the matter under the Drugs & Magic Remedies (Objectionable Advertisements) Act, 1954 will taken in case such advertisements are found to be contravening any of the provision of the said Act.



Latest News
Bullets Image Delhi Budget 2022-23 Citizen Participation
Bullets Image For any Covid related information or queries please call 1031.
Bullets Image Common Assistant Accounts Officer(Civil) Examination 2021(Part-I and Part-II)
Bullets Image Revised SOP, with new points of CCRGA, CAG, for the release of Government Advertisements for all Departments of GNCT of Delhi (13.04.2017)
Bullets Image Intimation regarding Comprehension Test on RTI Act, 2005 for the year-2016 to beheld on 17.02.2017 (Friday)

National Voters Service Portal
Local Services
Important Links
Drugs Control Department Govt of NCT of Delhi
Last Updated : 11 Jan,2019